ArticleBMJ open2026

Cost-effectiveness analysis of efavirenz versus ainuovirine in people living with HIV initiating first-line combination antiretroviral therapy.

Chenlu Yang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.